PersonaDx
PersonaDx brings precision oncology to clinics by using RNA profiles and AI to guide metastatic cancer treatment. Its lead assay, PersonaCRC, classifies metastatic colorectal cancer with tumor RNA data and a neural network model. The platform operates in CLIA-certified labs and integrates with existing oncology workflows. Its AI engine creates multimodal data sets to accelerate therapeutic development and inform AI training. Overall, the company targets expanding precision medicine for metastatic diseases at scale, improving outcomes for oncology patients.
PersonaDx
PersonaDx brings precision oncology to clinics by using RNA profiles and AI to guide metastatic cancer treatment. Its lead assay, PersonaCRC, classifies metastatic colorectal cancer with tumor RNA data and a neural network model. The platform operates in CLIA-certified labs and integrates with existing oncology workflows. Its AI engine creates multimodal data sets to accelerate therapeutic development and inform AI training. Overall, the company targets expanding precision medicine for metastatic diseases at scale, improving outcomes for oncology patients.